NASDAQ: NYXH - Nyxoah S.A.

Yield per half year: +41.05%
Sector: Healthcare

Share chart Nyxoah S.A.


About

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. Nyxoah S.A. was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.


Main settings

Цена ао 13.37
Выручка 6.9E-5
EBITDA -0.0067
Число акций ао 0.02797 млрд
P/S 532.92
P/BV 3.06
EV/EBITDA -0.4126
ISIN BE0974358906
Сайт https://www.nyxoah.com
Change price per day: -1.2209% (9.01)
Change price per week: -19.09% (11)
Change price per month: -46.32% (16.58)
Change price per 3 month: +107.51% (4.289)
Change price per half year: +41.05% (6.31)
Change price per year: -10.01% (9.89)
Change price per year to date: +87.37% (4.75)


All parameters ⇨

Grade

Underestimation

Title Value Grade
P/S 532.92 1
P/BV 3.06 9
P/E 0 0
EV/EBITDA -0.4126 0
Total:

Efficiency

Title Value Grade
ROA, % -31.98 0
ROE, % -39.56 0
Total:

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total:

Debt

Title Value Grade
Debt/EBITDA -0.2928 10
Total:

Growth impulse

Title Value Grade
Profit growth, % 62.65 10
Share price growth, % 0 0
Dividend growth, % 0 0
Total:

Main owners

Institutions Volume Share, %
Blackrock Inc. 653984 2.28
Opaleye Management Inc. 344800 1.2
AXA S.A. 221700 0.77
Sio Capital Management, LLC 200076 0.7
Putnam Investments LLC 192942 0.67
Deerfield Management Company, L.P. (Series C) 174842 0.61
Rossmore Private Capital 117940 0.41
PURA VIDA INVESTMENTS, LLC 111467 0.39
DekaBank Deutsche Girozentrale 33200 0.12
Goldman Sachs Group Inc 18208 0.06

Similar companies



Company management

Head Job title Payment Year of birth
Mr. Robert Taub MBA Co-Founder & Chairman 138.32k 1947 (77 years)
Mr. Olivier Taelman CEO & Executive Director 684.06k 1972 (52 years)
Mr. Loic Moreau Chief Financial Officer 343.6k 1981 (43 years)
Mr. Bruno Onkelinx Chief Technology Officer N/A
Mikaela Kirkwood Corporate Communication & Investor Relations Manager N/A
Ms. An Moonen General Counsel N/A
Mr. Remi Renard Vice President of Market & Market Access N/A
Ms. Inge Vanwittenbergh Global Human Resource Director N/A
Mr. David M. DeMartino Chief Strategy Officer N/A
Mr. Jeyakumar Subbaroyan Chief Clinical Officer N/A

About company

Address: Belgium, Mont-Saint-Guibert, Rue Edouard Belin 12 - open in Google maps, open in Yandex maps
Website: https://www.nyxoah.com
Phone: +tel:3210222355